Praxis Precision Medicines, Inc. Share Price

Praxis Precision Medicines, Inc. Share Price

NASDAQ: PRAX | Mid Cap
$285.90
-$3.22 (-1.11%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Praxis Precision Medicines, Inc. Stock Performance

Open
$283.59
Prev. Close
$289.12
Circuit Range
N/A
Day Range
$280.98 - $289.42
Year Range
$154.45 - $392.31
Volume
15,820
Average Traded
$284.94

Praxis Precision Medicines, Inc. Share Price Today

As of 31 October 2026, Praxis Precision Medicines, Inc.'s share price is $285.90. The stock opened at $283.59, compared to its previous close of $289.12. During today's trading session, Praxis Precision Medicines, Inc.'s share price traded between $280.98 and $289.42, with an average price of $285.20. Over the past 52 weeks, the stock has recorded a high of $392.31 and a low of $154.45. In terms of performance, Praxis Precision Medicines, Inc.'s share price has declined by 10.64% over the last six months and is up 43.89% on a year-on-year basis.

Praxis Precision Medicines, Inc. Share Price Chart

Line chart of the Praxis Precision Medicines, Inc. price trend over the selected period. The price fell overall, ranging from 282.14 to 289.42, ending at 285.50.
$280.98$289.42
L
Show Current Price
H

Praxis Precision Medicines, Inc. Stock Fundamentals & Key Indicators

Market Cap
$6.43B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-12.15
Revenue (TTM)
$0.00
Return On Equity (TTM)
-25.29%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-13.24%

Praxis Precision Medicines, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$73.93-$88.91-$92.56-$83.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-20.26%-4.11%9.55%

Praxis Precision Medicines, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$2.45$8.55$0.00
Net Profit-$214.03-$123.28-$182.82-$303.27
Net Profit MarginN/A-5031.84%-2138.25%N/A
Income ChangeN/A42.40%-48.30%-65.88%

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Praxis Precision Medicines, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$288.50
$286.10
-1.97%
Sep 2026
$352.09
$291.86
-20.77%
Aug 2026
$298.05
$368.37
+19.75%
Jul 2026
$333.60
$307.61
-8.22%
Jun 2026
$341.35
$335.16
-4.61%
May 2026
$313.27
$351.36
+9.82%
Apr 2026
$326.49
$319.93
-0.66%
Mar 2026
$330.00
$322.05
-4.36%
Feb 2026
$312.91
$336.74
+7.15%
Jan 2026
$291.22
$314.26
+6.45%
Dec 2025
$193.81
$295.22
+50.32%
Nov 2025
$183.11
$196.40
-1.15%

PRAX Share Price FAQs